Adaptive Biotechnologies Corporation (FRA:1HM)
15.11
-0.15 (-0.95%)
Jan 16, 2026, 4:00 PM EST
Adaptive Biotechnologies Revenue
Adaptive Biotechnologies had revenue of $93.97M USD in the quarter ending September 30, 2025, with 102.38% growth. This brings the company's revenue in the last twelve months to $252.75M, up 42.57% year-over-year. In the year 2024, Adaptive Biotechnologies had annual revenue of $178.96M with 5.10% growth.
Revenue (ttm)
$252.75M
Revenue Growth
+42.57%
P/S Ratio
11.04
Revenue / Employee
$408.33K
Employees
619
Market Cap
2.38B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 178.96M | 8.68M | 5.10% |
| Dec 31, 2023 | 170.28M | -15.03M | -8.11% |
| Dec 31, 2022 | 185.31M | 30.96M | 20.06% |
| Dec 31, 2021 | 154.34M | 55.96M | 56.88% |
| Dec 31, 2020 | 98.38M | 13.31M | 15.65% |
| Dec 31, 2019 | 85.07M | 29.41M | 52.83% |
| Dec 31, 2018 | 55.66M | 17.22M | 44.77% |
| Dec 31, 2017 | 38.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mainova AG | 3.89B |
| Gelsenwasser AG | 3.36B |
| Paul Hartmann AG | 2.44B |
| Lechwerke AG | 1.06B |
| tonies SE | 510.38M |
| Maschinenfabrik Berthold Hermle AG | 469.42M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Northern Data AG | 200.27M |
Adaptive Biotechnologies News
- 18 days ago - What's Going On With Adaptive Biotechnologies Shares Tuesday? - Benzinga
- 19 days ago - Adaptive Biotechnologies Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
- 19 days ago - Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 19 days ago - Adaptive Biotechnologies Rises 10% As Revenue Surges Over 50% - Nasdaq
- 19 days ago - Adaptive Biotechnologies (ADPT) Surpasses Q4 Revenue Estimates, Shares Climb - GuruFocus
- 19 days ago - Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 23 days ago - Insider Sell: Harlan Robins Sells Shares of Adaptive Biotechnologies Corp - GuruFocus
- 24 days ago - Chad Robins Sells 124,998 Shares of Adaptive Biotechnologies Corp - GuruFocus